174 related articles for article (PubMed ID: 15719851)
1. Severe hypocalcaemia associated with extensive osteoblastic metastases in a patient with prostate cancer.
Fokkema MI; de Heide LJ; van Schelven WD; Hamdy NA
Neth J Med; 2005 Jan; 63(1):34-7. PubMed ID: 15719851
[TBL] [Abstract][Full Text] [Related]
2. A man with osteoblastic metastasis and hypocalcaemia.
Lim SC; Tan CE; Aw TC; Khoo D; Eng P; Ho SC; Tai ES; Fok A
Singapore Med J; 2000 Feb; 41(2):74-6. PubMed ID: 11063207
[TBL] [Abstract][Full Text] [Related]
3. Zoledronic acid-induced severe hypocalcaemia in a prostate cancer patient with extensive osteoblastic bone metastases.
Patel K; Brahmbhatt V; Ramu V
Tenn Med; 2005 Feb; 98(2):83-5, 89. PubMed ID: 15779196
[TBL] [Abstract][Full Text] [Related]
4. Hypocalcemia due to avid calcium uptake by osteoblastic metastases of prostate cancer.
Szentirmai M; Constantinou C; Rainey JM; Loewenstein JE
West J Med; 1995 Dec; 163(6):577-8. PubMed ID: 8553652
[No Abstract] [Full Text] [Related]
5. Severe hypocalcaemia because of osteoblastic prostate carcinoma metastases.
Yener S; Demir O; Ozdogan O; Akinci B; Yesil S
Int J Clin Pract; 2008 Oct; 62(10):1630-1. PubMed ID: 18822033
[No Abstract] [Full Text] [Related]
6. Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease.
Tucci M; Mosca A; Lamanna G; Porpiglia F; Terzolo M; Vana F; Cracco C; Russo L; Gorzegno G; Tampellini M; Torta M; Reimondo G; Poggio M; Scarpa RM; Angeli A; Dogliotti L; Berruti A
Prostate Cancer Prostatic Dis; 2009; 12(1):94-9. PubMed ID: 18332901
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate stimulation of osteoblasts and osteoblastic metastasis as a mechanism of hypocalcaemia.
Ho JW
Med Hypotheses; 2012 Mar; 78(3):377-9. PubMed ID: 22206806
[TBL] [Abstract][Full Text] [Related]
8. Severe hypocalcemia due to osteoblastic metastasis of prostate cancer.
Diéguez Felechosa M; Noval Menéndez J; Manjón Miguelez L
Med Clin (Barc); 2017 Mar; 148(6):287-288. PubMed ID: 28118964
[No Abstract] [Full Text] [Related]
9. Prolonged hypocalcemia after treatment with zoledronic acid in a patient with prostate cancer and vitamin D deficiency.
Breen TL; Shane E
J Clin Oncol; 2004 Apr; 22(8):1531-2. PubMed ID: 15084635
[No Abstract] [Full Text] [Related]
10. Prostate-specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer.
Goya M; Ishii G; Miyamoto S; Hasebe T; Nagai K; Yonou H; Hatano T; Ogawa Y; Ochiai A
Prostate; 2006 Nov; 66(15):1573-84. PubMed ID: 16927388
[TBL] [Abstract][Full Text] [Related]
11. The clinical spectrum of hypocalcaemia associated with bone metastases.
Riancho JA; Arjona R; Valle R; Sanz J; González-Macías J
J Intern Med; 1989 Dec; 226(6):449-52. PubMed ID: 2489231
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
Dai J; Keller J; Zhang J; Lu Y; Yao Z; Keller ET
Cancer Res; 2005 Sep; 65(18):8274-85. PubMed ID: 16166304
[TBL] [Abstract][Full Text] [Related]
13. Hypocalcaemia of malignancy.
Schattner A; Dubin I; Huber R; Gelber M
Neth J Med; 2016 Jul; 74(6):231-9. PubMed ID: 27571720
[TBL] [Abstract][Full Text] [Related]
14. Hypocalcemia with osteoblastic metastases in patient with prostate carcinoma. A cause of secondary hyperparathyroidism.
Smallridge RC; Wray HL; Schaaf M
Am J Med; 1981 Jul; 71(1):184-8. PubMed ID: 7246580
[TBL] [Abstract][Full Text] [Related]
15. A case of extremely advanced prostate cancer presenting hemolytic jaundice.
Wakisaka M; Takagishi H
Hinyokika Kiyo; 1994 Mar; 40(3):261-3. PubMed ID: 8178748
[TBL] [Abstract][Full Text] [Related]
16. Natural history and treatment of bone complications in prostate cancer.
Saad F; Clarke N; Colombel M
Eur Urol; 2006 Mar; 49(3):429-40. PubMed ID: 16431012
[TBL] [Abstract][Full Text] [Related]
17. The bisphosphonate YM529 inhibits osteoblastic bone tumor proliferation of prostate cancer.
Yonou H; Ochiai A; Ashimine S; Maeda H; Horiguchi Y; Yoshioka K; Ogawa Y; Hatano T; Tachibana M
Prostate; 2007 Jun; 67(9):999-1009. PubMed ID: 17440967
[TBL] [Abstract][Full Text] [Related]
18. [Hypocalcemia in cancer of the prostate: existence of an antivitamin D factor?].
Arlet P; Blasco A; Duffaut M; Botreau Y; Le Tallec Y
Nouv Presse Med; 1980 May; 9(24):1714-5. PubMed ID: 7465407
[No Abstract] [Full Text] [Related]
19. Refractory hypocalcaemia complicating metastatic prostatic carcinoma.
Rizzo C; Vella S; Cachia MJ
BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26123464
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of osteoblastic bone metastasis of prostate cancer].
Yonou H; Ogawa Y; Ochiai A
Clin Calcium; 2006 Apr; 16(4):557- 64. PubMed ID: 16582505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
